A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) increases the risk of metabolic syndrome and non-alcoholic-fatty-liver disease (NAFLD). Vitamin D supplementation may exert positive effects on liver biochemistry in patients with NAFLD; however, its effects on PCOS are unknown. This randomized, double-blind, placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Zeeshan, Papageorgiou, Maria, Deshmukh, Harshal, Kilpatrick, Eric S., Mann, Vincent, Corless, Lynsey, Abouda, George, Rigby, Alan S., Atkin, Stephen L., Sathyapalan, Thozhukat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356309/
https://www.ncbi.nlm.nih.gov/pubmed/30658483
http://dx.doi.org/10.3390/nu11010188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356309/
https://www.ncbi.nlm.nih.gov/pubmed/30658483
http://dx.doi.org/10.3390/nu11010188

Ejemplares similares